FDA inspection
University of Southern California, DBA USC Molecular Imaging Center: FDA inspection ending Aug 9, 2018
FDA inspection 1066165 · Los Angeles, CA
Key facts
| Inspection ID | 1066165 |
|---|---|
| Firm | University of Southern California, DBA USC Molecular Imaging Center |
| FEI number | 3012058126 |
| Address | 2250 Alcazar St |
| City | Los Angeles |
| State | CA |
| ZIP | 90089-0107 |
| Fiscal year | 2018 |
| Inspection end date | Aug 9, 2018 |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data